In vitro susceptibility of Prototheca zopfii genotypes 1 and 2

Medical Mycology

Volumn 49, Issue 2, 2011, Pages 222-224

  Sobukawa, Hideto ^a   Kano, Rui ^a   Ito, Takaaki ^b   Onozaki, Masanobu ^c   Makimura, Koichi ^d   Hasegawa, Atsuhiko ^d   Kamata, Hiroshi ^a  

^a NIHON UNIVERSITY   (Japan)

^b Livestock Medical Center   (Japan)

^c KANTO CHEMICAL CO INC   (Japan)

^d TEIKYO UNIVERSITY   (Japan)

Author keywords

Drug susceptibility; E test; genotype; prototheca zopfii

Indexed keywords

AMPHOTERICIN B; GENTAMICIN; ITRACONAZOLE; KANAMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BOVINE MASTITIS; GENOTYPE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACOGENETICS; PROTOTHECA;

ANIMALS; ANTI-INFECTIVE AGENTS; CATTLE; GENOTYPE; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TESTS; PROTOTHECA;

BOVINAE; PROTOTHECA ZOPFII;

EID: 78751523535     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.511285     Document Type: Article

References (12)

1. Blaschke-Hellmessen R, Schuster H, Bergmann V. Differenzierung von Varianten bei Prototheca zopfi i (Krüger 1894). Arch Exp Veterinärmed 1985; 39 : 387-397.
2. Roesler U, Scholz H, Hensel A. Emended phenotypic characterization of Prototheca zopfi i : a proposal for three biotypes and standards for their identifi cation. Int J Syst Evol Microbiol 2003; 53 : 1195-1199.
3. Roesler U, Möller A, Hensel A, et al. Diversity within the current algal species Prototheca zopfi i : a proposal for two Prototheca zopfi i genotypes and description of a novel species, Prototheca blaschkeae sp. nov. Int J Syst Evol Microbiol 2006; 56 : 1419-1425.
4. Möller A, Truyen U, Roesler U. Prototheca zopfi i genotype 2-the causative agent of bovine protothecal mastitis? Vet Microbiol 2007; 370-374.
5. Osumi T, Kishimoto Y, Kano R, et al. Prototheca zopfi i genotypes isolated from cow barns and bovine mastitis in Japan. Vet Microbiol 2008; 131 : 419-423.
6. McDonald JS, Richard JL, Anderson AJ. Antimicrobial susceptibility of Prototheca zopfi i isolated from bovine intramammary infections. Am J Vet Res 1984; 45 : 1079-1080.
7. S hahan TA, Pore RS. In vitro susceptibility of P rototheca spp. to gentamicin. Antimicrob Agents Chemother 1991; 35 : 2434-2435.
8. Marques S, Silva E, Carvalheira J, et al. Short communication: i n vitro antimicrobial susceptibility of Prototheca wickerhamii and Prototheca zopfi i isolated from bovine mastitis. J Dairy Sci 2006; 89 : 4202-4204.
9. Lass-Florl C, Mayr A. Human protothecosis. Clin Microbiol Rev 2007; 230-242
10. Tortorano AM, Prigitano A, Dho G, et al. I n vitro activity of conventional antifungal drugs and natural essences against the yeast-like algae. Prototheca J Antimicrob Chemother 2008; 61 : 1312-1314.
11. Pore RS. Selective medium for the isolation of Prototheca . Appl Microbiol 1973; 26 : 648-649.
12. NCCLS; National Committee for Clinical and Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. Wayne, PA; National Committee for Clinical Laboratory Standards, 2002.